Relationship between human lymphocyte antigen-B27 and clinical features of psoriatic arthritis

Journal of Microbiology, Immunology and Infection

Volumn 36, Issue 2, 2003, Pages 101-104

  Tsai, Yi Giien ^a   Chang, Deh Ming ^b   Kuo, San Yuan ^b   Wang, Wei Ming ^b   Chen, Yi Chueng ^c   Lai, Jenn Haung ^b  

^a Christian Hospital   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c Armed Forces Sung Shan Hospital   (Taiwan)

Author keywords

Human lymphocyte antigen B27; Psoriatic arthritis

Indexed keywords

C REACTIVE PROTEIN; HLA B27 ANTIGEN;

ADULT; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; INTERPHALANGEAL JOINT; LABORATORY TEST; MALE; NAIL DISEASE; PROGNOSIS; PSORIATIC ARTHRITIS; RISK ASSESSMENT; SACROILIITIS;

ADULT; AGED; ARTHRITIS, PSORIATIC; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HLA-B27 ANTIGEN; HUMANS; JOINTS; MALE; MIDDLE AGED;

EID: 0037477423     PISSN: 02532662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gladman DD. Psoriatic arthritis. Rheum Dis North Am 1998;24:829-44.
2. Elkayam O, Ophir J, Yaron M, Caspi D. Psoriatic arthritis: interrelationship between skin and joint manifestations related to onset, cause and distribution. Clin Rheumatol 2000;19:301-5.
3. Gladman DD, Anhorn KA, Schahter RK, Merart H. HLA antigens in psoriatic arthritis. J Rheumatol 1986;13:586-92.
4. Suarez-Almazor ME, Russell AS. Sacroiliitis in psoriasis: relationship to peripheral arthritis and HLA-B27. J Rheumatol 1990;17:804-8.
5. Kao JS, Yu HS, Shey HM, Chen GS. HLA-A,B,C and DR in Chinese with psoriasis: relation to age of onset and clinical expression of the disease. J Formos Med Assoc 1987;86:259-63.
6. Gladman DD, Farewell VT. The role of HLA antigens as indicators of disease progression in psoriatic arthritis: multivariate relative mode. Arthritis Rheum 1995;38:845-50.
7. Gladman DD, Farewell VT, Kopciuk KA, Cook RJ. HLA markers and progression in psoriatic arthritis. J Rheumatol 1998;25:730-3.
8. Baker H. Prevalence of psoriasis in polyarthritic patients and their relatives. Ann Rheum Dis 1966;25:229-34.
9. Albrecht J, Muller HA. HLA-B27 typing by use of flow cytofluorometry. Clin Chem 1987;33:1619-23.
10. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994;264:1141-5.
11. James TE, Verna W. Psoriatic arthritis: clinical aspects and management. Dermatol Clin 1984;2:477-91.
12. Kanga U, Mehra NK, Larrea CL, Lardy NM, Kumar A, Feltkamp TE. Seronegative spondyloarthropathies and HLA-B27 subtypes: a study in Asian Indians. Clin Rhumatol 1996;15:13-8.
13. Barton AC, Bruce IN, Silman AJ. Genetic studies of psoriatic arthritis: dissecting joints and skin. J Rehumatol 2001;28:3-5.
14. Eastmond CJ. Psoriatic arthritis: genetics and HLA antigens. Baill Clin Rheumatol 1994;8:263-76.
15. Marsal S, Armadans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E. Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatol 1999;38:332-7.
16. Helliwell PS, Marchesoni A, Peters M, Platt R, Wright V. Cytidine deaminase activity, C reactive protein, histidine, and erythrocyte sedimentation rate as measures of disease activity in psoriatic arthritis. Ann Rheum Dis 1991;50:362-5.
17. Sox HC Jr, Liang MH. The erythrocyte sedimentation rate: guidelines for rational use. Ann Intern Med 1986;104:515-23.
18. Cohen MK, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. J Rheumatol 1999;26:1752-6.
19. Scofield RH, Kurien B, Gross T, Warren WL, Harley JB. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet 1995;345:1542-4.